@article{00759a229db84e149ffe6116d43e05c1,
title = "Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research",
abstract = "The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.",
keywords = "catheter, injection, myocardial regeneration, stem cells, training",
author = "Nabil Dib and Philippe Menasche and Bartunek, {Jozef J.} and Zeiher, {Andreas M.} and Andre Terzic and Chronos, {Nicolas A.} and Henry, {Timothy D.} and Peters, {Nicholas S.} and Francisco Fern{\'a}ndez-Avil{\'e}s and Magdi Yacoub and Sanborn, {Timothy A.} and Anthony DeMaria and Schatz, {Richard A.} and Taylor, {Doris A.} and Shmuel Fuchs and Silviu Itescu and Miller, {Leslie W.} and Dinsmore, {Jonathan H.} and Dangas, {George D.} and Popma, {Jeffrey J.} and Hall, {Jennifer L.} and Holmes, {David R.}",
note = "Funding Information: Dr. Dib has received research grants from Cardiovascular Biotherapeutics and Angioblast Systems, Inc. ; and consultant fees from Biologics Delivery Systems, Inc. (Cordis Corporation), and Cardio3 Biosciences. Dr. Bartunek has received research grants from Cardio3 Biosciences . Dr. Zeiher is an advisor and co-founder of t2Cure. Dr. Peters has received research grants from CardioPolymers Inc. and Medtronic, Inc. ; is a consultant and honorarium recipient from CardioPolymers Inc., Ablation Frontiers Inc., AstraZeneca Inc., Sanofi Aventis Inc., Magnetecs Inc., Bard Inc., and Bioheart Inc.; and has intellectual property and stock in CardioPolymers Inc. Dr. Sanborn is on the Speakers' Bureau of Merck; and is a Chairman and on the Data Safety Monitoring Board of St. Jude Medical. Dr. DeMaria has received research grants from Lantheus , Acusphere , CV Therapeutics , Cardiovascular Biotherapeutics , Angioblast Systems, Inc. , Philips Medical Systems , and General Electric Medical Systems ; and has stock options in Cardionet. Dr. Schatz has a licensing agreement with Biologics Delivery Systems and Cordis Corporation; is on the Scientific Advisory Board and Data Safety Monitoring Board of Baxter; and is a Speaker for Cordis Corporation and Medtronic, Inc. Dr. Itescu is President and founder of Angioblast Systems, Inc. Dr. Miller has received a research grant from Thoratec Corp . Dr. Dangas is a consultant for and has received honoraria from Cordis Corporation; and is a speaker for Cordis Corporation, Medtronic, Inc, and Boston Scientific. Dr. Popma has received research grants from Abbott Vascular , Boston Scientific , Cordis , ev3 , and Medtronic, Inc. Dr. Hall is a consultant for Catholic Healthcare West; and has received grants NIH - R01HL081715A1 and NIH - 1R21DK078029-01 . ",
year = "2010",
month = mar,
doi = "10.1016/j.jcin.2009.12.013",
language = "English (US)",
volume = "3",
pages = "265--275",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "3",
}